| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |